Daclizumab to Treat Chronic Immune Thrombocytopenia

Clinical trial NCT00049725 · COMPLETED

Trial details

NCT number: NCT00049725
Sponsor: National Institutes of Health Clinical Center (CC)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Thrombocytopenia

Start date: 2002-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.